February 27, 2020 / 9:34 AM / a month ago

BRIEF-Allogene Therapeutics Reports Q4 Loss Of $0.58 Per Share

Feb 27 (Reuters) - Allogene Therapeutics Inc:

* ALLOGENE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.58

* Q4 EARNINGS PER SHARE ESTIMATE $-0.69 — REFINITIV IBES DATA

* ALLOGENE THERAPEUTICS- EXPECTS FY 2020 GAAP NET LOSSES TO BE BETWEEN $260 MILLION AND $280 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below